Ophthalmic innovators have trusted our guidance for over 50 years. We’re leading the way in global ophthalmic product development through precision, expertise, and innovation.
This webinar delves into new clinical approaches and endpoints for glaucoma therapies, focusing on IOP-independent neuroprotection. It covers recent research, FDA considerations, and strategies to optimize therapeutic programs for glaucoma patients.